Les Meilleures Cliniques et Coûts des traitements d’obésité en Italie 2026

Italy is the first country globally to legally recognize obesity as a chronic, progressive, and relapsing disease. Under Law No. 149/2025, the Italian Senate shifted obesity from a lifestyle choice to a pathology. This legislation integrates obesity treatment into the National Health Service (SSN) framework.

• Universal access: Obesity care is now part of the Essential Levels of Care (LEA).
• National funding: Italy allocated 1.2 million Euros annually starting in 2027 for treatment.
• Anti-stigma laws: The legislation mandates measures against weight-based discrimination in schools and workplaces.
• Medical training: Specific budgets fund specialized obesity management training for general practitioners and psychologists.

Bookimed Expert Insight: While the 2025 law sets a global legal precedent, clinical expertise in Italy was already highly developed. IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan performs over 5,000 operations annually. Surgeons like Dr. Alessandro Giovanelli have completed over 9,000 procedures. This high volume ensures that legal recognition is backed by significant surgical experience and advanced technology like the da Vinci robot.

Patient Consensus: Patients note that while the law provides a framework, actual access to surgery under the public system requires meeting strict BMI thresholds. It remains essential to document all previous weight-loss attempts and comorbidities meticulously for insurance or health service approval.

Eligibility for bariatric surgery via the Italian National Health System requires a Body Mass Index of 40 or higher. Patients with a Body Mass Index of 35 may qualify if they have serious comorbidities. These conditions include type 2 diabetes, hypertension, or severe obstructive sleep apnea.

• Age range: Usually available for adults aged 18 to 65 years.
• Documented attempts: Patients must prove 6 months of supervised, unsuccessful weight loss.
• Psychological clearance: Mandatory mental health evaluation ensures readiness for permanent lifestyle changes.
• Clinical stability: Underlying health conditions must be medically managed before surgical intervention.

Bookimed Expert Insight: Italian centers of excellence show a clear preference for high-volume expertise. For example, Dr. Alessandro Giovanelli at IRCCS Ospedale Galeazzi - Sant'Ambrogio has performed over 9,000 operations. Choosing a surgeon with this volume often leads to better access to advanced technologies like the da Vinci robot, which is available in Milan and Rome clinics.

Patient Consensus: Patients note that meeting the strict BMI requirements is only the first step. Many emphasize that keeping detailed logs of past diets and exercise is essential to avoid application rejections.

In Italy, the Italian Medicines Agency (AIFA) authorizes semaglutide (Wegovy, Ozempic), liraglutide (Saxenda), and orlistat (Xenical) for weight management. Doctors prescribe these for patients with a BMI over 30. Specialists at clinics like San Raffaele in Milan also utilize naltrexone/bupropion (Mysimba) for appetite control.

• Approved GLP-1 analogs: Wegovy and Saxenda are primary injectable options for chronic weight loss.
• Diabetes medications: Ozempic and Mounjaro are prescribed off-label for significant weight reduction benefits.
• Oral therapies: Orlistat prevents 25% fat absorption and remains a common first-line treatment.
• Prescription requirements: All medications require a formal prescription from a GP or specialist.

Bookimed Expert Insight: While many patients seek GLP-1 injections, Italian medical centers like IRCCS Ospedale Galeazzi - Sant'Ambrogio often integrate these with surgical consultations. Data shows that high-volume centers performing over 5,000 operations annually prioritize long-term metabolic health. This suggests that medications are increasingly used as a bridge to, or in combination with, procedures like intragastric balloons, which may cost around $6,050 in specialized Milanese clinics.

Patient Consensus: Patients note that while Saxenda is widely available through GPs, newer drugs like Wegovy often face supply shortages. Many find that private endocrinologist visits in Milan or Rome provide faster access to prescriptions than the public health system.

To start obesity treatment in Italy, obtain a medical referral from a primary care physician to access the National Health Service (SSN) framework. Patients typically undergo multidisciplinary screenings at accredited centers. Specialized facilities like IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan offer advanced robotic and laparoscopic surgical interventions.

• Initial referral: Consult a family doctor to obtain an impegnativa for specialized obesity care.
• Specialized centers: Seek centers accredited by the Italian Obesity Society (SIO) for comprehensive pathways.
• Surgical eligibility: Bariatric surgery generally requires a BMI over 40 or 35 with complications.
• Robotic technology: High-volume hospitals in Milan and Rome utilize the da Vinci robotic system.

Bookimed Expert Insight: Italian centers like IRCCS Ospedale Galeazzi - Sant'Ambrogio provide high-tier surgical safety with specialists like Dr. Alessandro Giovanelli performing over 9,000 operations. Our data shows that top Milanese clinics often bundle language assistance and 3-4 days of hospitalization into surgical packages. This level of institutional experience is vital for complex revisions, as this specific hospital performs 75% of Italy's orthopedic revisions, signaling a strong culture of managing difficult cases.

Patient Consensus: Patients note that while the public system is affordable, waiting times can exceed 6 months, leading many to choose private care in Northern Italy for faster access. Many suggest keeping detailed records of your BMI and past weight loss attempts to speed up the surgical approval process.

Italy hosts nationally recognized centers for obesity treatment, primarily concentrated in Milan and Lombardy. Leading institutions include IRCCS Policlinico San Donato and IRCCS Ospedale Galeazzi-Sant’Ambrogio. These facilities hold IRCCS accreditation from the Italian Ministry of Health for excellence in clinical research and specialized bariatric care.

• IRCCS Ospedale Galeazzi-Sant’Ambrogio: A Milan-based facility performing over 9,000 bariatric operations.
• Specialized surgical techniques: Surgeons utilize laparoscopic and da Vinci robotic technology for precision.
• San Raffaele Hospital: Provides advanced gastric bypass and sleeve procedures led by expert professors.
• Multidisciplinary care teams: Accredited centers integrate endocrinologists, nutritionists, and psychologists for treatment.

Bookimed Expert Insight: While hospital reputation is vital, our data shows a significant technology gap in mid-range packages. IRCCS Ospedale Galeazzi-Sant’Ambrogio offers robotic-assisted procedures for approximately $30,000, which is nearly $10,000 more than standard laparoscopic options. For patients with high BMI or previous abdominal surgeries, the robotic platform's precision may justify this investment to ensure smoother recovery.

Patient Consensus: Patients note that private care in Milan or Bologna significantly reduces waiting times compared to the 18-month national health service queues. Many recommend verifying if surgeons personally perform at least 100 cases annually to ensure the highest safety standards.